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Background: The Crabtree-negative yeast species Kluyveromyces lactis has been established as an attractive
microbial expression system for recombinant proteins at industrial scale. Its LAC genes allow for utilization of the
inexpensive sugar lactose as a sole source of carbon and energy. Lactose efficiently induces the LAC4 promoter,
which can be used to drive regulated expression of heterologous genes. So far, strain manipulation of K. lactis by
homologous recombination was hampered by the high rate of non-homologous end-joining.
Results: Selection for growth on lactose was applied to target the insertion of heterologous genes downstream of
the LAC4 promoter into the K. lactis genome and found to yield high numbers of positive transformants.
Concurrent reconstitution of the β-galactosidase gene indicated the desired integration event of the expression
cassette, and β-galactosidase activity measurements were used to monitor gene expression for strain improvement
and fermentation optimization. The system was particularly improved by usage of a cell lysis resistant strain,
VAK367-D4, which allowed for protein accumulation in long-term fermentation. Further optimization was achieved
by increased gene dosage of KlGAL4 encoding the activator of lactose and galactose metabolic genes that led to
elevated transcription rates. Pilot experiments were performed with strains expressing a single-chain antibody
fragment (scFvox) and a viral envelope protein (BVDV-E2), respectively. scFvox was shown to be secreted into the
culture medium in an active, epitope-binding form indicating correct processing and protein folding; the E2 protein
could be expressed intracellularly. Further data on the influence of protein toxicity on batch fermentation and
potential post-transcriptional bottlenecks in protein accumulation were obtained.
Conclusions: A novel Kluyveromyces lactis host-vector system was developed that places heterologous genes
under the control of the chromosomal LAC4 promoter and that allows monitoring of its transcription rates by
β-galactosidase measurement. The procedure is rapid and efficient, and the resulting recombinant strains contain
no foreign genes other than the gene of interest. The recombinant strains can be grown non-selectively in rich
medium and stably maintained even when the gene product exerts protein toxicity.Background
Kluyveromyces lactis is one of few yeast species that can
utilize lactose as a sole source of carbon and energy.
It can be isolated from dairy products and is used at
industrial scale for preparation of the enzyme lactase
(β-galactosidase). K. lactis received considerable interest
as a eukaryotic cell factory for heterologous protein* Correspondence: karin.breunig@genetik.uni-halle.de
1Institute of Biology, Martin-Luther University Halle-Wittenberg, Halle 06120,
Germany
Full list of author information is available at the end of the article
© 2012 Krijger et al.; licensee BioMed Central
Commons Attribution License (http://creativec
reproduction in any medium, provided the orproduction due to physiological properties that distin-
guish it from Saccharomyces cerevisiae [1-3]. In particu-
lar, the Crabtree effect, which in S. cerevisiae leads to the
repression of respiration under aerobic conditions, is
absent or less pronounced in K. lactis allowing for high
dilution rates and high biomass yields in fermentation
processes [4-6].
With the recombinant expression of prochymosin in
K. lactis, an industrial process was established the
product of which is used in cheese manufacturing [1].
The approval of K. lactis-derived proteins in the foodLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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organism, which is an important aspect, for example, in
the development of K. lactis-based oral vaccines that
represents a major goal of our work [7].
A K. lactis-based expression system is commercially
available that makes use of the strong, inducible LAC4 pro-
moter to drive the expression of heterologous proteins
[3,8]. LAC4 is one of the two LAC genes, not found in
S. cerevisiae, that are responsible for lactose assimilation. It
encodes β-galactosidase and is divergently transcribed and
co-regulated with the lactose permease gene LAC12. The
LAC genes are located in a subtelomeric position, and
polymorphic sites have been reported [9]. The LAC4 pro-
moter, which has been extensively studied [10-12], is sub-
ject to transcriptional activation by KlGal4 (also termed
Lac9), a homologue of the prototypic S. cerevisiae transac-
tivator Gal4 [12-14]. KlGal4 is activated by intracellular
galactose derived from cytosolic lactose hydrolysis or up-
take of external galactose. Activation is controlled by a
feedback regulatory network consisting of the KlGal4 in-
hibitor, KlGal80, and the bi-functional protein KlGal1
[15,16]. KlGal1 catalyses the conversion of galactose into
galactose-1-phosphate, the first step in galactose assimila-
tion [17]. In addition to this enzymatic activity, KlGal1
functions as an inducer of KlGal4 by binding to and inacti-
vating KlGal80 [18].
Here we describe a novel strategy for stable, heterol-
ogous gene expression in K. lactis that makes use of
KlGal4 to drive regulated or constitutive transcription and
growth on lactose to select for integration of transgenes at
the LAC locus. In the described host-vector system,
β-galactosidase activity parallels transcription of the trans-
gene and can be used in the establishment of fermentation
protocols and selection of strains with elevated transcrip-
tion. In two pilot studies we demonstrate successful secre-
tion of a single-chain antibody fragment (scFvox) andTable 1 Kluyveromyces lactis strains




RULOx/D802 RULOx PLAC4-scFvox Klgal80Δ2::ScURA3
VAK367 CBS 2359/152 metA ura3-5
VAK367-D4 VAK367 lac4::ScURA3
VAK726 VAK367-D4 PLAC4-E2-1BVDV
VAK746 VAK367-D4 PLAC4-E2-1BVDV Klgal80Δ2::ScURA
VAK834 726VAK PLAC4-E2-1BVDV (pLI-1)
VAK836 VAK726 PLAC4-E2-1BVDV (pLI-1)4
VAK906 VAK726 PLAC4-E2opt (pLI-1)n
a gene encoding oxazolon specific single-chain antibody fragment.
b E2-1 segment of the bovine viral diarrhea virus (strain CP7) containing the E2 ORF
c yeast codon-optimized synthetic gene corresponding to VSV-E2(MTdel), which lacintracellular production of a viral envelope protein, the E2
protein of bovine viral diarrhea virus (BVDV). Expression
of viral antigens in food-grade yeast strains is a first step
towards development of yeast-based oral vaccines. As
described elsewhere recombinant K. lactis cells could be
directly used for vaccination using the strategy reported
here [Arnold et al, PLoS One, in press].
Material and methods
K. Lactis strains
Strain RUL1888 MATa ura3-59, a ura3 derivative of
CBS2359 (NRRL Y-1140), was obtained from Dr. Yde
Steensma (Leiden University, NL). RUL1888-D4 was gener-
ated by one-step gene disruption replacing LAC4 sequences
between +358 and +1181 by the ScURA3 gene. The anti-
oxazolone single-chain antibody (scFvox)-producing strain
RULOx was generated by replacing the ScURA3 gene with
a scFvox expression cassette by homologous recombination.
Strain VAK367 metA ura3-5 was derived from CBS2359/
152 [19] via two rounds of mutagenesis selecting for
5-fluoroorotic acid resistance and screening for high stabil-
ity in stationary phase and killer-negative phenotype.
VAK367-D4 is a lac4::ScURA3 derivative of VAK367, analo-
gous to RUL1888-D4. VAK367-D4-derived recombinant
strains are listed in Table 1.
Plasmids
Plasmid KIp3 is an integrative K. lactis vector for homolo-
gous integration at the LAC4 or lac4::ScURA3 locus. It
consists of a ColE1 derived E. coli vector with the ampicil-
lin resistance gene and an expression cassette based on the
LAC4 promoter and TEF1 terminator that are separated by
a unique SalI site for insertion of genes of interest. The
TEF1 terminator is followed by the KlGAL80 promoter
and the 5'-end of the LAC4 open reading frame. The cas-
sette was generated by fusion-PCR in multiple stepsHeterologous gene Reference

















and 5’ and 3’ flanking sequences.
ks the membrane anchor and is derived from BVDV strain NADL [22].
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vector backbone by cleavage e.g. with HpaI, which creates
flanking regions of homology of 1 and 1.3 kbp, respectively.
KIpOx is a derivative of KIp3 containing the S.cerevisiae
alpha-factor prepro sequence fused to the scFvox sequence
with a C-terminal c-myc tag (derived from plasmid
pHEN1-1 [20]). KIp3-E2-1 [7] is a derivative of KIp3 con-
taining the coding sequence of the C-terminus of BVDV-
E1 (including the signalase E1/E2cleavage site) and the
full-length coding sequence of the BVDV-E2 (strain BVDV
CP7, nucleotides 2273–3580; [21]; inserted as a SalI-XhoI
fragment into the unique SalI site. In strain VAK906 this
fragment was replaced by a yeast codon-optimized syn-
thetic gene corresponding to VSV-E2(MTdel), which lacks
the membrane anchor and is derived from BVDV strain
NADL [22]. pLI-1 is an ScURA3-based integrative vector
carrying the KlGAL4 gene (LAC9-1 allele) [23].
Fermentation
Fermentations were carried out in a DasGip parallel bio-
reactor system (DasGip AG, Jülich, Germany) with four
2 L fully equipped fermenters. For growth studies, parallel
processes were operated in a batch mode with a working
volume of 0.7 L. YP medium (2% peptone, 1% yeast ex-
tract) was supplemented with mineral salts, methionine,
uracil, adenine (20 mg/L each), and niacin (12 mg/L). Start
lactose concentration was set to 30 g/L. The temperature
of the yeast culture was maintained at 30°C and the dis-
solved oxygen level was controlled to 30% saturation. A
pH value of 5.0 was controlled during the process via
addition of 2 M NaOH and 2 M H3PO4. Samples were
taken from the culture broth during the process to deter-
mine OD600, residual lactose and ethanol concentrations.
One OD600 unit corresponds to 0.38 g/L dry cell weight.
Immunofluorescence microscopy
K. lactis strain VAK726 was grown in YPLac medium
(2% peptone, 1% yeast extract, 0.5% lactose), followed by
formaldehyde fixation (5% final concentration) for 3 h at
30°C. After washing the cells with sorbitol buffer (50 mM
HEPES; 1 M sorbitol, pH 7.5), cell walls were degraded
with cell wall degrading enzymes (zymolyase 10 mg/ml
and glusulase, 1:4) for about 30 min. Protoplasts were col-
lected by centrifugation, and resuspended in sorbitol buf-
fer, followed by permeabilization of the cell membrane
with 0.1% Triton X-100 (in sorbitol buffer). 20 μl of the
suspension was applied to poly-L-lysine-coated object
slides. The dried slides were washed 3 times in PBS. After
blocking (3% BSA; 0.1% cold fish gelatin, 0.1% Triton
X-100; 0.05% Tween20) a 90 min incubation with a
monoclonal anti-E2-antibody, [WB-214 (PA2020; c.c.pro,
Germany); 1:100 in blocking solution] was performed, fol-
lowed by 90 min incubation with a secondary antibody
(Dylight 488, Dianova; 1:100 in blocking solution). Inaddition, cell nuclei and plasma membranes were stained
with DAPI (1 μg/ml) and DiL C18 (Invitrogen; 1:1000 in
PBS), respectively. Fluorescence signals were recorded with
a confocal laser scanning microscope (TCS SP5, Leica).
DAPI fluorescence (absorption 358 nm; emission 461 nm)
was excited with a DPSS Laser (405 nm); DyLight488 (ab-
sorption 493 nm; emission 518 nm) with an Argon Laser
(488 nm) and DilC18 (absorption 549 nm; emission
565 nm) with a HeNe Laser (543 nm).
Preparation of BSA-oxazolone
Bovine serum albumin (BSA)-oxazolone conjugate was
produced according to Mäkelä et al. [24]. Briefly, 75 mg of
oxazolon (4-Ethoxymethylene-2-phenyl-2-oxazolin-5-one;
Sigma E-0753) was added to 20 ml of 50 mg/ml BSA
(Albumin bovine Fraction V, pH 5.2, Serva 11922) in 5%
(w/v) NaHCO3 and shaken gently for 24 h at 4°C. After
centrifugation for 30 min at 30,000 x g, the supernatant
was dialysed three times against 2 L of 0.15 M NaCl at 4°C
with gentle stirring, each step at least 12 h. The concentra-
tion of oxazolone was calculated from the absorption at
352 nm of the dialysate, diluted with 0.15 M NaCl to give
values between 0.1 and 0.6 (E352 = 32,000 M
-1 cm-1). After
determination of the BSA concentration, the coupling
ratio was calculated and lay typically between 19 and 26
moles of oxazolone per mol of BSA with a final BSA con-
centration of 19–44 mg/ml. The dialysate was supplemen-
ted with an equal volume of glycerol and stored at −20°C
in 100 μl aliquots.
ELISA for scFvox detection
Microtiter plates (NUNC Maxisorp) were coated by fill-
ing the wells with 120 μl of BSA-oxazolone conjugate,
diluted 1:1000 in 0.1 M NaCO3 pH 8.0. Filled plates
were wrapped with parafilm and incubated overnight at
4°C. After incubation, the plates were emptied by vigor-
ous shaking, filled with 120 μl of Blocking Reagent
(Roche 1 112 589) diluted 1:10 in distilled water and
gently shaken on a vortex for 15 sec. This procedure was
repeated three times. Finally the wells were filled with
120 μl of Blocking Reagent and incubated at room
temperature for 1.5 hours. Supernatants from 5 mlK.
lactis cultures (WT and scFvox-producing strains grown
in YP with the indicated carbon sources at 120 rpm and
30°C for up to 110 hours) were two-fold diluted serially
(undiluted to 16-fold dilution). The samples were mixed
with equal volumes of Blocking Reagent and 100 μl were
filled in the wells of the blocked plate, followed by 1
hour incubation at room temperature. After incubation,
the plates were washed as before, filled with 100 μl of
primary antibody (anti-c-myc antibody, Roche 1 667
149), diluted 1:5000 in Blocking Reagent and incubated
at room temperature for 1 hour. After washing, wells
were filled with 100 μl secondary antibody (anti mouse
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Reagent and the plate was incubated at room temperature
for 1 hour. After incubation, the plate was washed with
substrate buffer (3.25 mM Na-perborate, 40 mM Na-
citrate, 60 mM Na2HPO4, pH 4.5, stored at 4°C) and filled
with 100 μl ABTS (Roche 1 112 422, 1 tablet per 50 ml of
substrate buffer, stored at 4°C in darkness) per well. Read-
ing was performed in a Tecan Sunsrise microplate reader,
taking 405 nm/450 nm difference readings with 1 min
intervals for 20 min with 10 sec. shaking between read-
ings. Amounts of scFvox were determined by comparing
ΔA405 for the supernatant samples to serial dilutions of a
reference scFvox preparation of known concentration,
purified from Nicotiana tabacum [25].
Dot blots for BVDV-E2 detection
After growth for 8 h in YPLac medium, cells were harvested
and protein extracts were prepared by glass bead disruption.
10 μl of protein extracts, adjusted to the same concentra-
tion, were applied to a nitrocellulose membrane (GE Health-
care). After drying and blocking (2% BSA in PBS) the
membrane was incubated with an anti-E2-antibody (WB-
214; 1:100) for 90 min, followed by incubation with the sec-
ondary infrared-labeled antibody (anti-ms-IRDy-800CW;
LI-COR Biosciences, 1:500) for another 90 min. Fluores-
cence signals were detected with an Odyssey infrared im-
aging system (LI-COR Bioscience). Excitation and emission
wavelengths were 493 nm and 518 nm, respectively.
Northern blotting
Yeast RNA was isolated by phenol-chloroform extraction
as described [26]. 5 μg total RNA was separated by agar-
ose/formaldehyde gel electrophoresis (1% agarose; 1x
MOPS buffer: 0.04 M MOPS, 10 mM sodium acetate,
1 mM EDTA, pH 7; 3.7% formaldehyde) and blotted to
HybondTM-N+ (GE Healthcare) membrane. After UV-
cross-linking, the membranes were subjected to hybri-
dization with RNA probes generated by in vitro transcrip-
tion with T7RNA polymerase (Fermentas). Template DNAs
were generated by PCR amplification of E2 and LAC4
sequences with one primer introducing the T7 promoter
sequence. Primer sequences were T7-E2-r (TAATACG A
CTCACTATAGGGAGATTAGGACTCA GCGAAGTAAT
C) and T-Tef REV (TGGAATTGTGAGCGGATAAC) for
E2; LAC4-right_T7_Promoter (TAATACGACTCACTAT
AGGACAGCTTCATCAACCCCGTAT) and LAC4Sonde
Right (CTTGAACGCTTTGAGTGCAG) for LAC4.
KlGAL4 copy number determination by qPCR
Yeast chromosomal DNA was isolated and KlGAL4 DNA
content was determined in strains VAK834 and VAK836
by qPCR using primers KlGAL4q-F (CAGCAAAG TG
CAGGTGAATG) and KlGAL4q-R (AACTCCTTGCACC
GTATGAC) for the KlGAL4 gene and ACT1qPCR-FWD(ACGCTCCAAGAGCCGTCTTC) and ACT1qPCR-REV
(TATCATCCCAGTTGGTAACG) for KlACT1, which
served as the reference single copy gene. DNA amplifica-
tion was recorded by SYBR-green fluorescence in an IQ5
real-time PCR system (BioRad). The copy number of
KlGAL4 in VAK906 was shown by semi-quantitative PCR
to be at least two but was not quantified precisely.
Results and discussion
Α β-galactosidase based selection strategy for stable
transformation of K. Lactis
Though multicopy episomal vectors are available for
K. lactis, transformants often accumulate segregants
without plasmid, even under selective conditions. This
phenomenon is particularly pronounced with plasmids
coding for proteins that exert a cytotoxic effect when
expressed at high quantity in the yeast cell. To overcome
this drawback and to generally improve K. lactis as a host
system for heterologous protein expression, this study
aimed at establishing a straight-forward procedure for the
generation of stable, recombinant K. lactis strains. For a
regulated and reproducible gene expression, these strains
should carry an expression cassette integrated at a defined
chromosomal position downstream of the LAC4 pro-
moter. Additionally, the K. lactis recombinants should dis-
play characteristics that enable reproducible growth in an
inexpensive medium and under non-selective conditions
without loss of the expression cassette.
Along these lines, we generated a lactose-deficient mu-
tant K. lactis strain in which the LAC4 gene was dis-
rupted by the ScURA3 gene. Complementary, an
integrative vector was constructed that permits the in-
sertion of heterologous genes of choice between the
LAC4 promoter-5’UTR sequence and a transcription ter-
minator, the latter of which is followed by the KlGAL80
promoter and the 5’ portion of the LAC4 ORF (Figure 1).
Cleavage of this plasmid with suitable restriction
enzymes generates a fragment with 1 and 1.3 kbp flank-
ing regions that, via homologous recombination, can re-
place the lac4::ScURA3 disruption cassette and restore
an intact LAC4 ORF. Regeneration of the intact LAC4
(β-galactosidase) gene allows for growth on lactose as a
sole carbon source and thus enables the selection of the
desired recombinant strains. In a second screening step,
the loss of the Ura+ phenotype serves as a marker to dis-
tinguish between a true replacement event and an unin-
tentional insertion of the entire plasmid downstream of
the lac4::ScURA3 locus, which can also restore an intact
LAC4 gene (see below). Typically, a transformation ex-
periment with 5 μg of cleaved plasmid DNA gave 20 to
50 Lac+ transformants 80% of which were Ura-.
In such correctly generated recombinant strains, the
heterologous gene ends up at the subtelomeric LAC
locus. It is controlled by the natural LAC4 promoter and
Figure 1 Host-vector system for insertion of "your favorite gene (YFG)" downstream of the LAC4 promoter. The K. lactis LAC4 gene
encoding β-galactosidase is divergently transcribed with the lactose permease gene (LAC12) and both genes are essential for growth on lactose.
Disruption of LAC4 is required to apply selection. In the lac4::ScURA3 strain (VAK367-D4) the sequences between +358 and +1181 of the LAC4 ORF
were replaced by the ScURA3 gene by homologous recombination. The expression cassette contains YFG fused to the LAC4 promoter, flanked at
the 3'-end by the TEF1 terminator, the KlGAL80 promoter and the 5'-end of LAC4. It can be excised from the vector backbone by cleavage with e.
g. HpaI. The resulting fragment can replace the ScURA3 gene and restore the LAC4 ORF by homologous recombination giving the PGAL80-LAC4
fusion gene. Desired recombinants are selected for growth on lactose plates. Bottom: Genome structure of BVDV with E2 gene, which was
inserted as an example YFG in the pilot experiment giving strain VAK726.
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transcription of the divergent LAC4 and LAC12 genes
[11]. Since expression of the LAC4 ORF is now under
control of the weaker KlGAL80 promoter [27], the
β-galactosidase levels produced by the recombinants are
lower than that of the isogenic LAC4 parent strain. The
use of the KlGAL80 promoter to drive LAC4 expression
accordingly serves two purposes: it avoids a tandem du-
plication of the LAC4 promoters, which could lead to
the loss of the insert, and it allows using β-galactosidase
activity as an indicator of heterologous gene transcrip-
tion (see below).
Expression studies with a secreted model protein
The novel K. lactis host-vector system was next evaluated,
first with a model gene encoding the single-chain antibodyfragment anti-oxazolone-scFv with a C-terminal c-myc epi-
tope (scFvox; [25]). To direct the recombinant protein to
the secretory pathway, the scFvox coding gene was fused to
the S. cerevisiae prepro-alpha factor sequence. The initial
host strain was derived by LAC4 gene disruption as
described [11] using strain RUL1888 (H.Y. Steensma, Univ.
Leiden). After homologous recombination and selection of
transformants on lactose plates, we screened for the
Ura- phenotype and tested for integration of the expression
cassette by PCR and Southern analysis. All transformants
tested had restored the LAC4 gene, and the Ura- pheno-
type resulted, as expected, from the desired one-step gene
replacement that brought the scFvox gene under the com-
mand of the LAC control region. In these transformants,
the scFvox gene represented YFG (“your favorite gene”;
Figure 1) and was the only heterologous sequence in the
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formants that were still Ura+ had restored the LAC4 gene
by integration of the entire plasmid with the expression
cassette in single or multiple copies, and scFvox expression
was driven by the truncated LAC control region present on
the transforming DNA (not shown).
To test for expression of the antibody fragment, several
recombinants were pre-grown in glucose, shifted to lac-
tose medium (time 0), and culture supernatants were ana-
lyzed by PAGE and Western blotting. A single band
at 29 kDa, corresponding approximately to the expected
size for the mature scFvox (28 kDa), was detected, indicat-
ing that the prepro-signal sequence had been removed
and that the protein had passed through the secretory
pathway. As expected, protein expression was inducible
by lactose, confirming KlGal4-regulated transcription
(Figure 2A). Consistently, knock-out of the KlGAL80 gene
(strain RULOx/D802), which encodes the negative regula-
tor of KlGal4, resulted in high expression levels of scFvox
in the absence of the inducing sugars (Figure 2B).Figure 2 Analysis of production of anti-oxazolone single-chain antibo
RULOx. Soluble scFvox in supernatants of YNB-cultures pregrown in glucose
blotting. The reference lane contains 15 ng of purified scFvox. B) Constitutiv
disruption of the KlGAL80 gene higher levels of soluble scFvox were presen
lane contains 5 ng of purified scFvox. C) Long-term cultivation in glucose o
the Klgal80 mutant strain expressing scFvox (RULOx/D802 strain). Cell densi
protein content (diamonds) in culture supernatant as determined by ELISAELISA experiments revealed that the heterologously
expressed protein was delivered to the culture medium and
bound the oxazolone antigen. The protein in the culture
supernatant was quantified using a purified scFvoxmyc
reference protein produced in Nicotiana tabacum (kindly
provided by Dr. U. Conrad) as a standard. The specific
binding activity of the yeast derived protein was identical to
the one purified from plant cells. This indicates that
K. lactis produced correctly folded scFvOx and the affinity
for the antigen was not affected by yeast specific
modifications.
As described earlier, due to incomplete inactivation of
the KlGal4 inhibitor under inducing conditions [27],
higher LAC4-controlled protein levels could be obtained
in the Klgal80 mutant than in the induced wild type par-
ent. In a first, non-optimized fermentation process of
strain RULOx/D802 up to 4.4 mg/liter scFvox protein
was obtained with a maximum at 48 hours of batch cul-
tivation (Figure 2C). In glucose the level of scFvox was
about 2–3 fold higher than in glycerol grown cells. Indy fragment scFvOx. A) Inducible expression of scFvox in strain
, 0, 2 and 4 hrs after induction by lactose was detected by Western
e expression of scFvox in strain RULOx/D802 (Klgal80Δ). Upon
t in supernatants of glucose- than lactose-grown cells. The reference
r glycerol medium (2% and 3% initial concentration, respectively) of
ty (squares) is plotted with oxazolone-binding activity (triangles) and
and SDS-PAGE, respectively, against the pure reference protein.
Krijger et al. Microbial Cell Factories 2012, 11:112 Page 7 of 12
http://www.microbialcellfactories.com/content/11/1/112both media there was a good correlation between the ac-
cumulation of protein and binding activity. However, for
unknown reasons, the binding activity dropped at late
times in the batch process, while the protein appeared to
be stable in Western analysis.
We had no evidence for intracellular protein accumula-
tion or cell toxicity exerted by scFvox. Compared to Pichia
pastoris, an established yeast host system for high level
single chain antibody expression [28-31], K. lactis did not
reach the high cell densities and productivity in our non-
optimized system. However, we have reason to believe that
considerable improvement can be achieved by optimizing
fermentation protocols and strain backgrounds. A very
promising aspect of the K. lactis system is the low level of
proteinase secretion and the solubility of the scFvox.
With strain RULOx/D802 (Klgal80) Coomassie staining
of culture supernatants revealed an unexpectedly large
number of additional proteins. Moreover, β-galactosidase
activity could be detected in the culture medium (not
shown) at late time points of the cultivation, indicating
cell lysis and release of cytoplasmic enzymes. The strain
RULOx did not differ from the Klgal80 mutant derivative
in this respect (except that β-galactosidase activity was
much lower). Cell lysis occurred in the stationary phase
and was also detected in the non-recombinant parent
strain RUL1888 (Figure 3A), ruling out that the instability
was caused by expression of the heterologous protein.
In fact, among a series of K. lactis wild type and labora-
tory strains that were subsequently screened, the majority
showed extracellular β-galactosidase indicating that in
many K. lactis strains cytosolic proteins are released by cell
lysis. Crossing the RUL1888 strain to JA6 [32], a stableFigure 3 Leakage of K. lactis proteins into the culture medium. A) Stra
48 hrs (lane 4) in YP medium with an initial concentration of 0.04% galacto
between JA6/D4 and RUL1888 were grown for 24 (lane 1), 48 (lane 2), 72 (
applied to SDS-PAGE and gels were stained after electrophoresis by Coomstrain with 1000- fold lower extracellular β-galactosidase
activity than RUL1888, resulted in diploids that behaved
like the RUL1888 parent suggesting that the cell lysis
phenomenon was dominant (Figure 3B). A high correlation
was observed between high β-galactosidase activity in the
culture supernatant and high protein content in the growth
medium. We thus used this simple enzymatic assay to gen-
erate an alternative K. lactis host strain for heterologous
protein expression, VAK367, that did not show significant
cell lysis. VAK367 originated from a Ura- derivative of
CBS2359/152 [19]; it had undergone two rounds of muta-
genesis and surprisingly was much more stable than the
grandparent CBS2359 (data not shown). Disruption of the
LAC4 gene in VAK367 using the lac4::ScURA3 knock-out
cassette (see above) did not change this property (data not
shown). Thus, the resulting strain, VAK367-D4 met ura3
lac4::ScURA3, was subsequently used as our standard host
for the integration of heterologous genes.
Expression of the E2 envelope protein of bovine viral
diarrhea virus (BVDV)
The above described selection and integration strategy
was used to express several viral structural proteins. As
described elsewhere, highly stable virus-like particles
could be produced upon expression of murine polyoma
virus VP1 in a Klgal80 mutant strain (Simon et al., sub-
mitted). Here we report a pilot experiment on the
expression of BVDV-E2 (termed E2 in this text), a highly
antigenic envelope protein of the important animal
pathogen bovine viral diarrhea virus (BVDV). For this
purpose, the BVDV ORF encoding the C-terminus of the
envelope protein E1 and the entire E2 was amplifiedin RUL1888 was grown for 6 (lane 1), 24 (lane 2), 30 (lane 3) and
se. B) Strain RUL1888, JA6 and a diploid strain resulting from a cross
lane 3) and 96 hrs (lane 4) in 1% galactose. Culture supernatants were
assie brilliant blue.
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into the KIp3 vector (E2-1 allele). An endogenous
signal sequence and signal peptidase cleavage-site in the
E1 portion should direct the expressed protein to the
ER-membrane and enable correct processing of the E2
N-terminus [33]. After cleavage of the plasmid with
HpaI, which releases the expression cassette, transform-
ation into VAK367-D4 and selection for growth on lac-
tose were performed. The E2-1 allele was successfully
integrated at the LAC4 locus (Figure 1, bottom line) as
verified by PCR and Southern blotting (data not shown).
The resulting strain was named VAK726.
Expression of the E2 protein and its intracellular
localization were analyzed by immunofluorescence in in-
tact yeast cells grown on lactose medium (Figure 4). These
data indicated association of the recombinant E2 with
intracellular membranes, most likely of the endoplasmic
reticulum (ER). Further experiments are needed to con-
firm E2 localisation.Figure 4 Detection of E2 protein expression in yeast cells by immuno
contains the BVDV-E2 ORF in single copy under control of the LAC4 promo
by confocal microscopy after staining with DAPI (panels b), E2-specific anti
antibody (Dylight 488; Dianova) (panels c) and Dil18 (Invitrogen) for stainin
is merged in panels a. C) Overlay of DNA, membrane-, and E2- staining rev
in the ER.Regulated versus constitutive expression of E2
As shown above for scFvox and elsewhere for the polyoma
VP1 (Simon et al., submitted), higher protein levels were
obtained in a Klgal80 mutant conferring constitutive ex-
pression from the LAC4 promoter. Likewise, when the
KlGAL80 gene of VAK726 was disrupted the resulting
Klgal80 mutant, strain VAK846, displayed higher E2-1
mRNA levels than the induced parent strain with a
high correlation between E2-1 and LAC4 mRNA levels
(Figure 5). On the downside, the Klgal80 mutation was
found to reduce the fitness of the strain K. lactis VAK746.
That is, on β-galactosidase indicator plates containing
X-Gal (5-bromo-4-chloro-indolyl-galactopyranoside) white
colonies were repeatedly observed with this strain. PCR
analysis of these colonies revealed that they had lost the
expression cassette as well as the downstream LAC4
gene. We assumed that these variants were under posi-
tive selection due to the toxicity of the heterologous pro-
tein product when produced constitutively and at highcytology. K. lactis strains VAK367 (A) and VAK726 (B and C), which
ter, were grown under inducing conditions (2% lactose) and analyzed
body WB-214 (PA2020; c.c.pro, Germany) and a polyclonal secondary
g of the plasma membrane (panels d). E2 and nuclear (DAPI) staining
eals accumulation of E2 in perinuclear regions suggesting localization
Figure 5 Comparison of regulated vs. constitutive expression
of E2-1 mRNA by Northern analysis in relation to LAC4 mRNA.
Total RNA was isolated from cultures grown in 0.5% glucose or
lactose as indicated, separated by agarose gel electrophoresis and
analyzed by hybridization with Digoxigenin (Roche)-labelled LAC4- or
E2-specific RNA probes, respectively. Ethidiumbromide staining of
rRNA served as a loading control (top panel).
Figure 6 Influence of elevated KlGAL4 gene dosage on E2 and
LAC4 mRNA levels. The E2-1-expressing strains VAK834 and VAK836
(Table 1) contain one and four tandem copies, respectively, of
plasmid pLI-1 carrying KlGAL4 in addition to the endogenous KlGAL4
gene copy. mRNA was prepared from cells grown in 0.5% lactose
and quantified by RT-qPCR using KlACT1 as a reference.
Figure 7 Quantification of E2 protein levels in different
congenic K. lactis strains. A) Dot blots performed in triplicates with
10, 25 and 50 μg of crude cell lysates from parent strain VAK367, the
E2-producing strain VAK726; the Klgal80 mutant derivative of VAK726
(VAK746); and the two derivatives of VAK726 carrying two (VAK834)
and five (VAK836) copies of the KlGAL4 gene, respectively. Cell
lysates were applied to nitrocellulose membranes and incubated
with E2-specific antibody WB-214 (PA2020; c.c.pro, Germany) and
polyclonal secondary antibody (Dylight 488; Dianova). B) Relative
fluorescence signal intensities were quantified as described in
Material and Methods and are given relative to strain VAK726.
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to a regulated expression of the E2 protein.
Increased KlGAL4 gene dosage causes elevated
expression
A major advantage of the described genomic integration
strategy is that the transcription regulation of the heter-
ologous gene and of the β-galactosidase gene follows
similar rules. Considering that transcription mediated by
the LAC4 as well as the KlGAL80 promoter is elevated
at higher concentrations of KlGal4 [23,34,35], we next
tested whether E2 expression could be shifted by in-
creasing the KlGAL4 gene dosage.
Accordingly, a KlGAL4 containing plasmid, pLI-1
[23], was integrated at the KlGAL4 locus of VAK726,
and Ura+ transformants were screened for elevated
β-galactosidase activity on X-Gal-containing glucose pla-
tes. Interestingly, blue staining on glucose turned out to
be a reliable marker for multiple integration of the
KlGAL4 plasmid, probably due to an imbalance between
KlGal4 and KlGal80. Tandem arrangement of the KlGAL4
gene copies was verified by PCR, and the gene copy num-
ber was determined by qPCR. Two strains containing 2
(strain VAK834) and 5 copies (strain VAK836) of the
KlGAL4 gene were further analyzed. E2-1 mRNA levels
were two and six-fold higher in strains VAK834 and
VAK836, respectively, compared to VAK726 and showed a
high correlation with LAC4 mRNA levels (Figure 6).
To compare E2 protein levels in these yeast strains we
established a dot-blot assay (Figure 7A) since denatured
E2 was undetectable with the available antibodies. E2
protein present in BVDV-infected cell lysates served as a
reference. Quantification of signal intensities in the dot-
blot assay indicated a 20% increase of the protein level
Table 2 Comparison of the fermentation process in three
different E2 expression strains




VAK726 0.21 0.24 0.29 7.6
VAK834 0.25 0.13 1.13 5.1
VAK906 0.27 0.15 0.84 10.7
aμ, specific growth rate in exponential phase; bYXS, biomass yield from
substrate; cYEX, ethanol per biomass;
dXf, final biomass (after 26 hrs).
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five-copy strain (Figure 7B). Thus, the increase in tran-
script levels only partially translates into higher protein
levels suggesting limitations at the level of translation or
protein stability. We have clear indications that codon
bias is one important factor limiting translation of viral
genes in K. lactis [Arnold et al., in revision]. The expres-
sion of yeast codon optimized synthetic genes can cir-
cumvent this problem.
Influence of elevated KlGAL4 gene dosage on
fermentation of E2 production strains
The two E2 expressing strains VAK726 and VAK834
were compared in batch fermentation with an initial lac-
tose concentration of 3%. The additional KlGAL4 gene
copy in VAK834 caused a significantly higher growth
rate in the exponential phase (Figure 8). However, this
was associated with lower yield and increased ethanol
production (Table 2). At later time points strain VAK726
overtook VAK834 and after 26 hours had accumulated
higher biomass levels.
Another E2 production strain, VAK906, which contains
at least two KlGAL4 gene copies, showed a different behav-
ior. It resembles VAK834 in the initial fermentation phase
but does not level off later. This indicates that the lower
biomass accumulation of VAK834 is not due to the ele-
vated KlGal4 concentration per se. Rather, the increased
expression of the E2-1 protein appears to exert protein tox-
icity not found in VAK906. The E2 gene in VAK906 wasFigure 8 Comparison of biomass accumulation of three E2 protein ex
medium (3% initial concentration) was performed in a DasGip parallel biore
conditions (see Material and Methods). Biomass accumulation is plotted ag
strain CP7, VAK906 contains an E2 allele from BVDV strain NADL [22]. VAK83derived from another viral isolate and deviates in several
aspects from the E2-1 allele present in VAK726 and
VAK834 (see Material and methods). It remains to be clari-
fied which property favors the performance in fermenta-
tion. The results demonstrate the benefit that is eventually
gained from moderate KlGal4 overexpression. However,
very high levels of the transactivator exert toxicity even in
a strain containing no heterologous genes [36].
Conclusions
Here we present a new strategy to efficiently target
heterologous genes to a specific location in a K. lactis
chromosome for expression under the K. lactis LAC4
promoter. It differs from established expression systems
in the following aspects:
(i). About 80% of the transformants selected on lactose
medium are Ura- and have replaced the lac4::
ScURA3 disruption cassette by the transgene under
the control of the complex LAC4 promoter despitepressing strains. Batch fermentation in supplemented YP-lactose
actor system (DasGip AG, Jülich, Germany) under controlled
ainst process time. VAK726 and VAK834 express the E2-1 allele of BVDV
4 and VAK906 carry multiple copies of the KlGAL4 transactivator gene.
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recombination in K. lactis.
(ii). No heterologous marker genes are used for
selection of transformants; instead selection
depends on reconstitution of the K. lactis
β-galactosidase gene in a lac4 mutant background
allowing for growth on lactose. Thus, the gene of
interest is the only heterologous gene in the
resulting recombinant strain.
(iii). There is no need for a 5-fluoroorotic acid (FOA)
selection step, which may result in cryptic
mutations, to select for replacement of the lac4::
ScURA3 disruption. Since lac4 disruptions can be
easily generated using dominant markers and X-Gal
indicator plates for mutant selection, any
prototrophic host strain, including polyploid
industrial production strains, can be engineered to
meet the requirements of this host-vector system.
(iv). Expression of β-galactosidase is driven by the
KlGAL80 promoter, the activity of which parallels
LAC4 promoter activity. This allows optimizing
fermentation protocols and strain improvement
by simple established enzymatic assays.
(v). The recombinant strains are stable even when the
gene product exerts cytotoxicity and can be grown
under non-selective conditions in complex media
if desired.
With the regulated production of an anti-oxazolone sin-
gle-chain antibody and the bovine viral diarrhea virus enve-
lope protein E2 we further confirmed the suitability of K.
lactis as a eukaryotic microbial host for secretion and intra-
cellular production of heterologous proteins that are other-
wise difficult to express recombinantly. The inducible
LAC4 promoter can easily be converted into a strong con-
stitutive promoter by gene disruption of the transcription
inhibitor KlGal80 but, depending on the introduced heter-
ologous gene, protein toxicity may become an issue. We
demonstrated that inducible LAC4 promoter activity and
expression of the transgene could be further improved by
integration of additional copies of the KlGAL4 transcription
activator gene. However, in the case of the BVDV-E2-1 al-
lele cell viability dropped from >95% to <65% with elevated
KlGAL4 gene dosage (data not shown). Moreover, elevated
transcription rates did not directly correlate with protein
accumulation and post-transcriptional steps were uncov-
ered as potential bottlenecks. The regulated expression
under control of the LAC4 promoter nevertheless allowed
obtaining high recombinant protein expression levels.Additional file
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